Subsequently, IGF2BP3 was confirmed as an important m6A reader that promotes the stability of m6A-modified ANLN mRNA, which accounted for ANLN overexpression in ICC at the post-transcriptional level. The gene discussed is IGF2BP3; the disease is intrahepatic cholangiocarcinoma.